292 related articles for article (PubMed ID: 29560069)
1. Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline.
Lapoint J; Meyer S; Yu CK; Koenig KL; Lev R; Thihalolipavan S; Staats K; Kahn CA
West J Emerg Med; 2018 Mar; 19(2):380-386. PubMed ID: 29560069
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature.
Burillo-Putze G; Richards JR; Rodríguez-Jiménez C; Sanchez-Agüera A
Expert Opin Pharmacother; 2022 Apr; 23(6):693-702. PubMed ID: 35311429
[TBL] [Abstract][Full Text] [Related]
3. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
Hickey JL; Witsil JC; Mycyk MB
Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
[TBL] [Abstract][Full Text] [Related]
4. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.
Khattar N; Routsolias JC
Am J Ther; 2018; 25(3):e357-e361. PubMed ID: 28953512
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid hyperemesis syndrome: a review of the literature.
Deceuninck E; Jacques D
Psychiatr Danub; 2019 Sep; 31(Suppl 3):390-394. PubMed ID: 31488758
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid Hyperemesis Syndrome: A Review of the Presentation and Treatment.
Leu N; Routsolias JC
J Emerg Nurs; 2021 May; 47(3):483-486. PubMed ID: 33712244
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE-4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department.
Borgundvaag B; Bellolio F; Miles I; Schwarz ES; Sharif S; Su MK; Baumgartner K; Liss DB; Sheikh H; Vogel J; Austin EB; Upadhye S; Klaiman M; Vellend R; Munkley A; Carpenter CR
Acad Emerg Med; 2024 May; 31(5):425-455. PubMed ID: 38747203
[TBL] [Abstract][Full Text] [Related]
8. Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department.
Lee A; Coralic Z
Ann Pharmacother; 2022 Feb; 56(2):151-154. PubMed ID: 33998315
[TBL] [Abstract][Full Text] [Related]
9. SAEM GRACE: Dopamine antagonists and topical capsaicin for cannabis hyperemesis syndrome in the emergency department: A systematic review of direct evidence.
Sabbineni M; Scott W; Punia K; Manuja K; Singh A; Campbell K; MacKillop J; Balodis I
Acad Emerg Med; 2024 May; 31(5):493-503. PubMed ID: 37391387
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment.
Richards JR; Lapoint JM; Burillo-Putze G
Clin Toxicol (Phila); 2018 Jan; 56(1):15-24. PubMed ID: 28730896
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department.
Wagner S; Hoppe J; Zuckerman M; Schwarz K; McLaughlin J
Clin Toxicol (Phila); 2020 Jun; 58(6):471-475. PubMed ID: 31482758
[No Abstract] [Full Text] [Related]
12. Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review.
Richards JR; Gordon BK; Danielson AR; Moulin AK
Pharmacotherapy; 2017 Jun; 37(6):725-734. PubMed ID: 28370228
[TBL] [Abstract][Full Text] [Related]
13. Haloperidol, a Novel Treatment for Cannabinoid Hyperemesis Syndrome.
Witsil JC; Mycyk MB
Am J Ther; 2017; 24(1):e64-e67. PubMed ID: 25393073
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area.
Hernandez JM; Paty J; Price IM
CJEM; 2018 Jul; 20(4):550-555. PubMed ID: 28835305
[TBL] [Abstract][Full Text] [Related]
15. [Spontaneuos pneumomediastinum secondary to cannabinoid hyperemesis syndrome].
Hernández-Ramos I; Parra-Esquivel P; López-Hernández Á; Burillo-Putze G
An Sist Sanit Navar; 2019 Aug; 42(2):227-230. PubMed ID: 31133765
[TBL] [Abstract][Full Text] [Related]
16. Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?
Inayat F; Virk HU; Ullah W; Hussain Q
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28052951
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid Hyperemesis Syndrome During Pregnancy: A Case Report.
Andrews KH; Bracero LA
J Reprod Med; 2015; 60(9-10):430-2. PubMed ID: 26592070
[TBL] [Abstract][Full Text] [Related]
18. Resolution of Cannabinoid Hyperemesis Syndrome with Benzodiazepines: A Case Series.
Kheifets M; Karniel E; Landa D; Vons SA; Meridor K; Charach G
Isr Med Assoc J; 2019 Jun; 21(6):404-407. PubMed ID: 31280510
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department.
Richards JR
J Emerg Med; 2018 Mar; 54(3):354-363. PubMed ID: 29310960
[TBL] [Abstract][Full Text] [Related]
20. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.
Lee C; Greene SL; Wong A
Clin Toxicol (Phila); 2019 Sep; 57(9):773-777. PubMed ID: 30729854
[No Abstract] [Full Text] [Related]
[Next] [New Search]